1. Home
  2. SEER vs FAAS Comparison

SEER vs FAAS Comparison

Compare SEER & FAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEER
    SELLHOLDBUYas of a day ago
  • FAAS
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • SEER 2017
  • FAAS 2021
  • Country
  • SEER United States
  • FAAS Indonesia
  • Employees
  • SEER N/A
  • FAAS N/A
  • Industry
  • SEER Medicinal Chemicals and Botanical Products
  • FAAS
  • Sector
  • SEER Health Care
  • FAAS
  • Exchange
  • SEER Nasdaq
  • FAAS NYSE
  • Market Cap
  • SEER 143.3M
  • FAAS 115.9M
  • IPO Year
  • SEER 2020
  • FAAS N/A
  • Fundamental
  • Price
  • SEER $2.31
  • FAAS $0.42
  • Analyst Decision
  • SEER Hold
  • FAAS
  • Analyst Count
  • SEER 1
  • FAAS 0
  • Target Price
  • SEER $3.00
  • FAAS N/A
  • AVG Volume (30 Days)
  • SEER 206.5K
  • FAAS 199.7K
  • Earning Date
  • SEER 11-06-2024
  • FAAS 09-17-2024
  • Dividend Yield
  • SEER N/A
  • FAAS N/A
  • EPS Growth
  • SEER N/A
  • FAAS N/A
  • EPS
  • SEER N/A
  • FAAS N/A
  • Revenue
  • SEER $14,608,000.00
  • FAAS $57,730,593.00
  • Revenue This Year
  • SEER N/A
  • FAAS N/A
  • Revenue Next Year
  • SEER $34.78
  • FAAS N/A
  • P/E Ratio
  • SEER N/A
  • FAAS N/A
  • Revenue Growth
  • SEER N/A
  • FAAS 38.16
  • 52 Week Low
  • SEER $1.51
  • FAAS $0.40
  • 52 Week High
  • SEER $2.63
  • FAAS $13.99
  • Technical
  • Relative Strength Index (RSI)
  • SEER 45.81
  • FAAS 31.77
  • Support Level
  • SEER $2.20
  • FAAS $0.52
  • Resistance Level
  • SEER $2.52
  • FAAS $0.57
  • Average True Range (ATR)
  • SEER 0.12
  • FAAS 0.09
  • MACD
  • SEER -0.04
  • FAAS 0.01
  • Stochastic Oscillator
  • SEER 27.65
  • FAAS 4.44

Stock Price Comparison Chart: SEER vs FAAS

SEER
FAAS
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober0102030405060708090SEER VS FAAS

About SEER Seer Inc.

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.

About FAAS DIGIASIA CORP

DigiAsia Corp operates as a holding company. The majority of DigiAsia's operations are currently conducted through its majority-owned entities, controlled entities and corporate joint venture. It is among the first embedded fintech as a service (EFaaS) companies in Indonesia serving business-to-business-to-consumer (B2B2C) customers, such as large corporations and state-owned enterprises, as well as business-to-business (B2B) customers, such as micro, small and medium-sized enterprise (MSME) merchants, across various segments. It aims to be a fintech-enabling platform in Southeast Asia by accelerating financial inclusion through its licenses and technology stack and combining the benefits of technological innovation with traditional financial services.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use